These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Treatment results with dioxopromethazine nose drops]. Knothe J, Baerthold W, Aschoff E. Pharmazie; 1970 Feb 02; 25(2):121-4. PubMed ID: 4192880 [No Abstract] [Full Text] [Related]
3. [Evaluation of E-221-005 in inflammatory nasal diseases by double blind metod]. Baba S, Oashi M, Onoda T. Jibiinkoka; 1972 Feb 02; 44(2):153-7. PubMed ID: 4111383 [No Abstract] [Full Text] [Related]
9. [Experience in the use of a nose drop, Otrivin]. Mizukoshi O, Sasaki H, Imamura C, Kawamoto A, Hama H. Jibiinkoka; 1967 Sep 11; 39(9):1021-114. PubMed ID: 4170718 [No Abstract] [Full Text] [Related]
10. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)]. Rüggeberg F. Z Allgemeinmed; 1974 Apr 20; 50(11):535-7. PubMed ID: 4135074 [No Abstract] [Full Text] [Related]
12. [The action of an oral rhinological agent on the nasal mucous membrane (author's transl)]. Schumann K. MMW Munch Med Wochenschr; 1974 May 24; 116(21):1089-92. PubMed ID: 4135042 [No Abstract] [Full Text] [Related]
13. [Adverse effect of long-term use of vasoconstrictive drops on the nasal mucosa]. Burmeĭster LK, Butule EA. Vestn Otorinolaringol; 1975 May 24; (4):71-3. PubMed ID: 52936 [No Abstract] [Full Text] [Related]